646 related articles for article (PubMed ID: 33087136)
21. Interferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells.
Yan Y; Zheng L; Du Q; Cui X; Dong K; Guo Y; Geller DA
Br J Cancer; 2021 Jul; 125(1):101-111. PubMed ID: 33772151
[TBL] [Abstract][Full Text] [Related]
22. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
[TBL] [Abstract][Full Text] [Related]
23. Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S-phase arrest and promoting apoptosis through CHK1 pathway.
Wu F; Chen WJ; Yan L; Tan GQ; Li WT; Zhu XJ; Ge XC; Liu JW; Wang BL
Cancer Med; 2016 Feb; 5(2):370-85. PubMed ID: 26714930
[TBL] [Abstract][Full Text] [Related]
24. Gain of UBE2D1 facilitates hepatocellular carcinoma progression and is associated with DNA damage caused by continuous IL-6.
Zhou C; Bi F; Yuan J; Yang F; Sun S
J Exp Clin Cancer Res; 2018 Nov; 37(1):290. PubMed ID: 30482241
[TBL] [Abstract][Full Text] [Related]
25. Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice.
Tsai CL; Liu WL; Hsu FM; Yang PS; Yen RF; Tzen KY; Cheng AL; Chen PJ; Cheng JC
Hepatology; 2018 Feb; 67(2):586-599. PubMed ID: 28646552
[TBL] [Abstract][Full Text] [Related]
26. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Cai S; Bai Y; Wang H; Zhao Z; Ding X; Zhang H; Zhang X; Liu Y; Jia Y; Li Y; Chen S; Zhou H; Liu H; Yang C; Sun T
J Exp Clin Cancer Res; 2020 Jul; 39(1):135. PubMed ID: 32669125
[TBL] [Abstract][Full Text] [Related]
28. MiR-320b/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling.
Wang J; Zhao H; Yu J; Xu X; Jing H; Li N; Tang Y; Wang S; Li Y; Cai J; Jin J
Cancer Sci; 2021 Feb; 112(2):575-588. PubMed ID: 33251678
[TBL] [Abstract][Full Text] [Related]
29. DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair.
Li Y; Li H; Peng W; He XY; Huang M; Qiu D; Xue YB; Lu L
Mol Med Rep; 2015 Jul; 12(1):1328-34. PubMed ID: 25815686
[TBL] [Abstract][Full Text] [Related]
30. Xanthatin triggers Chk1-mediated DNA damage response and destabilizes Cdc25C via lysosomal degradation in lung cancer cells.
Tao L; Cao Y; Wei Z; Jia Q; Yu S; Zhong J; Wang A; Woodgett JR; Lu Y
Toxicol Appl Pharmacol; 2017 Dec; 337():85-94. PubMed ID: 29074359
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
Liu F; Zhu C; Gao P; Zheng S; Li C
Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
[TBL] [Abstract][Full Text] [Related]
32. Wnt/β-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune microenvironment in hepatocellular carcinoma.
Huang Y; Sheng H; Xiao Y; Hu W; Zhang Z; Chen Y; Zhu Z; Wu D; Cao C; Sun J
Radiother Oncol; 2021 Sep; 162():34-44. PubMed ID: 34214613
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase.
Wayne J; Brooks T; Massey AJ
Oncotarget; 2016 Dec; 7(51):85033-85048. PubMed ID: 27829224
[TBL] [Abstract][Full Text] [Related]
34. Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma.
Wild AT; Gandhi N; Chettiar ST; Aziz K; Gajula RP; Williams RD; Kumar R; Taparra K; Zeng J; Cades JA; Velarde E; Menon S; Geschwind JF; Cosgrove D; Pawlik TM; Maitra A; Wong J; Hales RK; Torbenson MS; Herman JM; Tran PT
PLoS One; 2013; 8(6):e65726. PubMed ID: 23762417
[TBL] [Abstract][Full Text] [Related]
35. DNA damage-dependent acetylation and ubiquitination of H2AX enhances chromatin dynamics.
Ikura T; Tashiro S; Kakino A; Shima H; Jacob N; Amunugama R; Yoder K; Izumi S; Kuraoka I; Tanaka K; Kimura H; Ikura M; Nishikubo S; Ito T; Muto A; Miyagawa K; Takeda S; Fishel R; Igarashi K; Kamiya K
Mol Cell Biol; 2007 Oct; 27(20):7028-40. PubMed ID: 17709392
[TBL] [Abstract][Full Text] [Related]
36. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
37. Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1.
Gagou ME; Zuazua-Villar P; Meuth M
Mol Biol Cell; 2010 Mar; 21(5):739-52. PubMed ID: 20053681
[TBL] [Abstract][Full Text] [Related]
38. XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer.
Wang W; Guo M; Xia X; Zhang C; Zeng Y; Wu S
Biomed Res Int; 2017; 2017():5718968. PubMed ID: 29082250
[TBL] [Abstract][Full Text] [Related]
39. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
Hao P; Kang B; Li Y; Hao W; Ma F
Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
[TBL] [Abstract][Full Text] [Related]
40. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma.
Liao J; Jin H; Li S; Xu L; Peng Z; Wei G; Long J; Guo Y; Kuang M; Zhou Q; Peng S
J Exp Clin Cancer Res; 2019 Nov; 38(1):454. PubMed ID: 31694662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]